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Unaffected relatives of individuals with non-syndromic cleft lip with or without cleft palate
(NSCL/P) show distinctive facial features. The presence of this facial endophenotype is
potentially an expression of underlying genetic susceptibility to NSCL/P in the larger
unselected population. To explore this hypothesis, we first partitioned the face into
63 partially overlapping regions representing global-to-local facial morphology and then
defined endophenotypic traits by contrasting the 3D facial images from 264 unaffected
parents of individuals with NSCL/P versus 3,171 controls. We observed distinct facial
features between parents and controls across 59 global-to-local facial segments at
nominal significance (p ≤ 0.05) and 52 segments at Bonferroni corrected significance
(p < 1.2 × 10−3), respectively. Next, we quantified these distinct facial features
as univariate traits in another dataset of 8,246 unaffected European individuals and
performed a genome-wide association study. We identified 29 independent genetic loci
that were associated (p < 5 × 10−8) with at least one of the tested endophenotypic
traits, and nine genetic loci also passed the study-wide threshold (p < 8.47 × 10−10).
Of the 29 loci, 22 were in proximity of loci previously associated with normal facial
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variation, 18 were near genes that show strong evidence in orofacial clefting (OFC),
and another 10 showed some evidence in OFC. Additionally, polygenic risk scores for
NSCL/P showed associations with the endophenotypic traits. This study thus supports
the hypothesis of a shared genetic architecture of normal facial development and OFC.
Keywords: NSCL/P, endophenotype, genetics, facial morphology, ALSPAC
INTRODUCTION
Orofacial clefting (OFC) is one of the most frequent congenital
malformations with a substantial functional, financial, and
mental health burden to the persons and families affected
(Wehby and Cassell, 2010). Non-syndromic cleft lip with or
without cleft palate (NSCL/P) has a multifactorial etiology, with
both environmental and genetic factors playing roles (Mangold
et al., 2011). To date, approximately 40 genetic risk loci have
been identified for non-syndromic clefts through genome-wide
association studies (GWAS; Thieme and Ludwig, 2017). Despite
the substantial number of loci discovered, the sample sizes
in these studies are relatively low when compared to GWA-
studies of schizophrenia (Schizophrenia Working Group of
the Psychiatric Genomics Consortium, 2014) or height (Wood
et al., 2014), which include over 100K individuals. Therefore,
it is likely that additional NSCL/P risk loci are yet to be
discovered. Furthermore, a thorough understanding of the roles
that these loci play in development, and thus the etiology of OFC,
is still lacking.
A comprehensive approach to studying the etiology of
NSCL/P requires investigations from different angles. One
approach is to study subclinical phenotypes that exist within
the range of normal development and are associated with OFC.
Such traits are referred to as endophenotypes, which can be
present in the biological relatives of individuals with NSCL/P
and are potentially an incomplete expression of susceptibility
loci for OFC (Gottesman and Gould, 2003; Weinberg et al.,
2006). A number of endophenotypes have been described
for NSCL/P, for example, a mild disruption of the upper
lip musculature (Neiswanger et al., 2007), the appearance of
“whorls” on the surface of the lower lip (Neiswanger et al.,
2009), dental anomalies (Howe et al., 2015), and altered facial
shape. In particular, unaffected relatives have been shown to
display midfacial retrusion and a broadening of the upper
face versus comparison control groups (Weinberg et al., 2009;
Roosenboom et al., 2015).
Extensive characterization of the NSCL/P facial
endophenotype allows us to investigate whether the presence of
facial endophenotypes indicates heightened genetic susceptibility
for NSCL/P. The possibility that NSCL/P risk variants influence
normal-range facial variation raises interesting questions about
the intersection of the genetic architecture between normal
and dysmorphic facial features. Some NSCL/P candidate genes
have already been shown to impact normal facial morphology.
Boehringer et al. (2011) found associations between two genetic
loci, rs1258763 and rs987525, involved in NSCL/P and normal
craniofacial traits, namely nose width and bizygomatic distance,
respectively. In previous work, we found that six known NSCL/P
risk variants affected nose, chin, eyebrow ridge, and philtrum 3D
shape in a large unselected population (Indencleef et al., 2018).
Moreover, in a recent GWAS of normal-range facial morphology
in Europeans, there was strong evidence of enrichment for genes
implicated in OFC and palate development (Claes et al., 2018).
In this study, we investigate the intersection of the genetic
architectures of normal facial variation and NSCL/P, starting
from explicitly defined NSCL/P facial endophenotypes. First, we
quantify the NSCL/P facial endophenotype at multiple levels
of scale, modeling both global and local facial shape variations
in a sample of unaffected parents of individuals with NSCL/P
(Claes et al., 2018). Next, we identify genetic loci affecting these
discovered facial endophenotypic traits in a GWAS of individuals
from the general population. Finally, we examine the extent to
which the genetic architecture of the facial endophenotypic traits
reflects a heightened susceptibility for OFC.
MATERIALS AND METHODS
Sample and Recruitment Details
This study involved two datasets, each consisting of two
cohorts. The EURO dataset contained 3D images and genome-
wide genotype data collected from the United States and
United Kingdom. These are individuals of European ancestry
recruited for studies of normal-range facial variation. The
PARENT dataset contained 3D images of unaffected parents of
individuals with NSCL/P and a group of unselected individuals
of normal-range facial variation (unaffected but no further
exclusion based on a family history in OFC). An overview of the
sample sizes is given in Table 1.
The United States samples in the EURO dataset originated
from the 3D Facial Norms cohort (3DFN) and studies at the
Pennsylvania State University (PSU) and Indiana University-
Purdue University Indianapolis (IUPUI). The United Kingdom
dataset included samples from the Avon Longitudinal Study
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of Parents and their Children (ALSPAC). Institutional review
board (IRB) approval was obtained at each recruitment site,
and all participants gave their written informed consent prior
to participation. For children, written consent was obtained
from a parent or legal guardian. The individuals of the
EURO dataset have been tested for associations with normal-
range facial morphology in previous work (Claes et al., 2018;
White et al., 2020a). In all datasets, participants with missing
information on sex, age, height, weight, or with insufficient image
quality were removed.
For the 3DFN sample, 3D images and genotype data were
obtained from the 3D Facial Norms repository (Weinberg
et al., 2016). The repository includes 3D facial surface images
and self-reported demographic descriptors as well as basic
anthropometric measurements from individuals recruited at four
United States sites: Pittsburgh, PA (PITT IRB PRO09060553
and RB0405013); Seattle, WA (Seattle Children’s IRB 12107);
Houston, TX (UT Health Committee for the Protection
of Human Subjects HSC-DB-09-0508); and Iowa City, IA
(University of Iowa Human Subjects Office IRB 200912764 and
200710721). Recruitment was limited to individuals aged 3–
40 years old and of self-reported European ancestry. Individuals
were excluded if they reported a personal or family history
of any birth defect or syndrome affecting the head or
face, a personal history of any significant facial trauma or
facial surgery, or any medical condition that might alter the
structure of the face. The intersection of unrelated participants
with quality-controlled images, covariates, and genotype data
from individuals of European descent resulted in 1,906
individuals for analysis.
The PSU sample included 3D images and genotypes of
participants recruited through several studies at the Pennsylvania
State University and sampled at the following locations: Urbana-
Champaign, IL (PSU IRB 13103); New York, NY (PSU IRB
45727); Cincinnati, OH (UC IRB 2015-3073); Twinsburg, OH
(PSU IRB 2503); State College, PA (PSU IRB 44929 and 4320);
Austin, TX (PSU IRB 44929); and San Antonio, TX (PSU IRB
1278). Participants self-reported information on age, ethnicity,
ancestry, and body characteristics, and data were gathered on
height and weight. Individuals were excluded from the analysis if
they were below 18 years of age and if they reported a personal
history of significant trauma or facial surgery, or any medical
condition that might alter the structure of the face. No restriction
on ancestry or ethnicity was imposed during recruitment, but
only individuals of European descent were used in this study.
The intersection of unrelated European participants with quality-
controlled images, covariates, and genotype data resulted in 1,990
individuals for analysis.
The IUPUI sample includes 3D images and genotypic
data from individuals recruited in Indianapolis, IN and
Twinsburg, OH (IUPUI IRB 1409306349). Participants self-
reported information on age, height, weight, and ancestry at the
time of the collection. Individuals who were below 18 years of age
were included if they had a parent or legal guardian’s signature.
No restrictions were placed on the recruitment of participants,
but only individuals of European descent and those meeting all
quality control criteria were used in this study (n = 784).
The United Kingdom sample was derived from the ALSPAC
dataset, a longitudinal birth cohort in which pregnant women
residing in Avon with an expected delivery date between April
1, 1991 and December 31, 1992 were recruited (Boyd et al.,
2013; Fraser et al., 2013). At the time, 14,541 pregnant women
were recruited and DNA samples were collected for 11,343
children. Genome-wide data was available for 8,952 subjects of
the B2261 study, titled “Exploring distinctive facial features and
their association with known candidate variants.” In addition to
this, 4,731 3D images were available along with information on
sex, age, weight, height, ancestry, and other body characteristics.
The ALSPAC study website contains details of all the data that is
available through a fully searchable data dictionary and variable
search tool (link available in the Web resources section). Image
quality control analysis resulted in the removal of 14 images
of poor quality, 199 participants were removed due to self-
reported non-European ancestry, 168 participants were removed
because of missing covariate data and 726 individuals were
removed because of relatedness. The intersection of participants
of European ancestry with quality-controlled images, covariates,
and genotype data included 3,566 individuals. Ethical approval
for the study was obtained from the ALSPAC Ethics and Law
Committee and the Local Research Ethics Committees. Informed
consent for the use of data collected via questionnaires and clinics
was obtained from participants following the recommendations
of the ALSPAC Ethics and Law Committee at the time. Consent
for biological samples has been collected in accordance with the
Human Tissue Act (2004).
Unaffected parents in the PARENT dataset were recruited
as part of the Pittsburgh Orofacial Cleft (POFC) project,
an international multi-center effort focused on understanding
the etiology of non-syndromic OFC (Weinberg et al., 2006).
The POFC project recruits individuals with clefts, their
family members, and population-based controls for extensive
phenotypic and genomic analyses. IRB approval was obtained
at each recruitment site, and all participants gave their
written informed consent prior to participation (PITT IRB
approvals: STUDY19080127 and CR19030367-003). As part
of the phenotyping protocol, 3D facial surface images were
captured. Only unaffected (i.e., without OFC) parents of children
with a non-syndromic form of cleft lip with or without cleft palate
and of European descent were included in the current study. The
unaffected parents were identified through index cases (affected
probands) served by local Craniofacial Centers or from birth
defects registries in the United States and Denmark. After image
quality control and only selecting individuals with information
on sex, age, weight, and height, 264 unaffected parents were
included in the analysis.
The group of unselected individuals (to serve as controls)
in the PARENT dataset was recruited either as part of normal-
range facial variation projects (EURO US Cohort described
above) or as controls for the POFC project. There was therefore
significant overlap between our unselected sample and the EURO
US cohort. In all cases, individuals in this group were excluded
if they reported a personal or family history of any birth defect
or syndrome affecting the head or face, a personal history of
any significant facial trauma or facial surgery, or any medical
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condition that might alter the structure of the face. Starting from
4,762 individuals, we selected for 3D images acquired with the
3dMDface camera system to avoid camera bias (White et al.,
2020b), and selected individuals older than 21, since the youngest
parent in the dataset was 22 at the time of image acquisition. This
selection resulted in 3,171 individuals.
Genotyping and Imputation
Due to the several genotyping platforms used for the EURO
US cohort (details in White et al., 2020a), we chose to impute
the samples from each platform separately and then combine
the imputed results (Verma et al., 2014). For each dataset,
standard data cleaning and quality assurance practices were
performed based on the GRCh37 genome assembly. Phasing was
performed using SHAPEIT2 (v2.r900) (Delaneau et al., 2013)
and imputation to the 1000G Phase 3 reference panel (The
1000 Genomes Project Consortium, 2015) performed using the
positional Burrows-Wheeler Transform (Durbin, 2014) pipeline
(v3.1) of the Sanger Imputation Server (v0.0.6) (McCarthy et al.,
2016). After post-imputation quality control and intersection
of imputed SNPs, a single merged dataset of all United States
participants was created with 7,417,619 SNPs for analysis.
The raw genotype data from the EURO UK cohort (ALSPAC)
was not available and restrictions are in place against merging
the ALSPAC genotypes with any others. For this reason, ALSPAC
genotypes, phased using SHAPEIT2 (Delaneau et al., 2013)
and imputed to the 1000G Phase 1 reference panel (Version
3) (1000 Genomes Project Consortium et al., 2012) using
IMPUTE2 (Howie et al., 2011), were obtained directly from the
ALSPAC database and held separately during the analysis. After
post-imputation quality control, the ALSPAC dataset contained
8,629,873 SNPs for analysis.
For both datasets, SNPs on the X chromosome were coded 0/2
for hemizygous males, to match with the 0/1/2 coding for females
(Shaffer et al., 2016).
Image Processing
The 3D facial images were obtained with digital facial
stereophotogrammetry systems or laser scanning systems. For the
3DFN sample and the PARENT dataset, 3D images were acquired
using the 3dMDface (3dMD, Atlanta, GA, United States) camera
system. PSU sample images were obtained with either the
3dMDface or Vectra H1 (Canfield Scientific, Parsippany, NJ,
United States) systems. The IUPUI sample was also imaged using
the Vectra H1 system. The ALSPAC sample was imaged using a
Konica Minolta Vivid 900 laser scanner (Konica Minolta Sensing
Europe, Milton Keynes, United Kingdom). All participants were
asked to have their mouths closed and to maintain a neutral facial
expression during image capture.
3D surface images of both the EURO and PARENT dataset
were imported into Matlab 2017b to perform the spatially dense
registration process in the MeshMonk registration framework
(White et al., 2019). Five positioning landmarks were roughly
indicated to establish a crude alignment of the images. Then,
each image was cleaned to remove hair, ears, and any dissociated
polygons. MeshMonk was then used to map a symmetric (relative
to the sagittal plane) anthropometric mask of 7,160 landmarks
onto the images and their reflections, which were constructed by
changing the sign of the x coordinate. This process resulted in
homologous configurations of spatially dense quasi-landmarks
for all images. Subsequently the original and reflected images
were aligned using Generalized Procrustes Analysis (GPA) to
eliminate differences in position, orientation and scale. Because
we only wish to study variation in symmetric facial shape in this
work, the original and reflected quasi-landmark configurations
were averaged and the resulting symmetric configurations were
used in further analyses.
After the registration, image quality control was performed
to identify poorly remapped faces using two approaches. First,
as described in Claes et al. (2018), outlier faces were identified
by calculating Z-scores from the Mahalanobis distance between
the cohort average and each individual face. Faces with Z-scores
higher than two were manually checked. Second, a score was
calculated that reflects the missing data present in the image
due to holes, spikes, and other mesh artifacts that can be caused
by facial hair or errors during the preprocessing steps. Images
with scores indicating a high amount of missing data were also
manually checked. During the manual check, the images were
either classified as images of poor quality or were preprocessed
and mapped again.
Global-to-Local Facial Phenotyping
To investigate facial shape on a global as well as a local scale,
a data-driven facial segmentation was performed in the EURO
dataset (Claes et al., 2018). Before segmentation, shape variables
were adjusted for sex, age, age-squared, height, weight, facial
size, the first four genomic ancestry axes, and the camera system
by removing their effect using PLSR (function plsregress from
Matlab 2017b) in the United States cohort and United Kingdom
cohort separately. After adjustment, the two cohorts were
combined, and the facial segments were defined by grouping
vertices that are strongly correlated using hierarchical spectral
clustering. The strength of covariation between quasi-landmarks
was defined using Escoufier’s RV coefficient (Klingenberg,
2009). The RV coefficient was then used to build a structural
similarity matrix that defined the hierarchical construction of
63 facial segments, broken into five levels, shown in Figure 1.
The configurations of each segment were then independently
subjected to a GPA to eliminate differences in rotation and
location, after which a PCA was performed in combination
with parallel analysis to capture the major variance in the facial
segments with fewer variables (Hayton et al., 2004).
Global-to-Local Regression-Based
Endophenotypes
To adjust for confounding variables in the PARENT dataset,
effects of sex, age, height, weight, and facial size were removed
using PLSR. After the segmentation in the EURO dataset,
the faces in the PARENT dataset were subjected to the same
segmentation, and their shapes were projected in the PCA space
of each segment. This was possible because all images were
mapped with the same facial template. Subsequently, the facial
phenotypes of the parents and the unselected individuals were
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FIGURE 1 | Global to local facial segmentation obtained using hierarchical spectral clustering.
contrasted in each of the 63 segments (Figure 1) by performing a
shape regression. Using PLSR, statistical significance was tested
following a permutation framework in which the effect size
(R2) was used as a test-statistic using 10,000 permutations. In
each segment, the PLSR returned one direction of effect or
trait, which is a vector in multidimensional shape space. Traits
defined in segments in which a nominally significant difference
between parents and unselected individuals was observed were
selected (p < 0.05) for further analysis and will be referred
to as endophenotypic traits. These endophenotypic traits are
not independent due to the overlapping construction of the
facial segments and the dependency between neighboring quasi-
landmarks of the facial template used in the registration.
A Bonferroni significance threshold (p < 1.2 × 10−3) was
calculated as 0.05/41, taking into account the multiple testing
of the effective number of independent traits. The number
of independent traits, 41, was calculated from the eigenvalues
of a correlation matrix containing the pairwise multivariate
correlations of all 63 traits (Li and Ji, 2005). Next, we quantified
the presence of each of the identified endophenotypic traits in the
EURO dataset. For each segment, the endophenotypic trait of that
segment and the individual’s 3D shape in that segment are points
or vectors in a multidimensional PCA space (Supplementary
Figure 1). We measured the cosine distance that operates on the
angle between two multi-dimensional vectors, one vector being
the endophenotypic trait and the other an individual’s face. The
lower the cosine distance, the more the endophenotypic trait is
present in the individual face. Therefore, the cosine distance is
a univariate score of the presence of the endophenotypic trait in
facial segments of an individual.
Genome Wide Association Analysis
A GWAS meta-analysis was performed on the endophenotypic
scores in the United States and United Kingdom cohorts. For
all analyses, the genotypes were coded additively based on the
presence of the major allele. In total, 7,417,619 SNPs overlapped
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in both the United States and the United Kingdom cohort and
were tested for association. In both cohorts, the endophenotypic
scores were tested for genotype–phenotype associations in
a standard linear regression with the SNP genotype as the
independent variable and the univariate endophenotypic scores
as the dependent variable (function regstats in Matlab 2017b).
This function employs a t-statistic. Finally, the associations
in the United States and the United Kingdom cohort were
meta-analyzed using inversed variance weighting (Begum et al.,
2012). Lead SNPs (i.e., the SNP with the smallest association
p-value for each locus) were annotated when at least genome-
wide significance (p < 5 × 10−8) was reached. Adjacent SNPs
were clumped within a 1 Mb window (±500 kb) as the same
signal of the lead SNP. Although annotations were performed
for loci based on a genome-wide threshold, the study-wide
Bonferroni threshold based on 59 tested traits was calculated
as 5 × 10−8/59 (p = 8.47 × 10−10). A lead SNP was defined
to show strong evidence for a role in OFC genetics if either
a gene in the vicinity (±500 kb) showed functional evidence
or if evidence from multiple research domains were found:
genetic association studies, animal studies, and/or clinical studies.
Weaker evidence was annotated to lead SNPs in the following
cases: suggestive associations with OFC, a single clinical case
study, a role in craniofacial development but not specifically in
OFC or associations in the same chromosomal band but more
than 500 kb removed from the lead SNP.
Polygenic Risk Scores for NSCL/P
To investigate whether the endophenotypic scores capture a
heightened genetic susceptibility for NSCL/P in an approach
complementary to the GWAS, we calculated polygenic risk
scores for NSCL/P in the EURO dataset. To this end, the
PRSice software (Choi and O’Reilly, 2019) was used to create
a model from the summary statistics of a previously published
NSCL/P meta-analysis (Leslie et al., 2017) based on individuals
of European descent only (N = 1,411). Mismatched SNPs were
removed by PRSice, and SNPs were clumped using an LD r2
threshold of 0.1 in a window of ±250 kb. Polygenic risk scores
were calculated with inclusion p-value thresholds ranging from
5 × 10−8 to 1 with a step size of 5 × 10−5, resulting in 104
sets of polygenic risk scores. Finally, for each inclusion threshold,
an association between the endophenotypic scores (independent
variable) and the polygenic risk scores (dependent variable) was
tested using linear regression (function regstats in Matlab2019b).
This was done for the United States and United Kingdom cohort
separately.
RESULTS
Facial shape in 59 out of 63 segments was found to
be different between unaffected parents of individuals with
NSCL/P and the unselected individuals at nominal significance
(p < 0.05), as shown in Figure 2. In 52 segments, a significant
difference was found below the Bonferroni-corrected threshold
(p < 1.3 × 10−3). Each shape regression returned a direction of
effect, represented by a vector in multidimensional shape space,
which we refer to as the endophenotypic trait. Endophenotypic
traits that were identified in segments 1, 2, 6, and 7 are
shown in Figure 3, respectively, covering the full face, the
midface, the mandibular region, and the upper facial region.
These endophenotypic traits illustrate a midfacial retrusion and
a broadening of the upper face, a more protruded chin, and
an upturned nose. All 59 global-to-local traits are visualized in
Supplementary Figure 2.
We identified 29 independent genetic loci with a lead SNP
associated with at least one of the 59 endophenotypic traits
below a genome-wide significance threshold (p < 5 × 10−8)
(Figure 4). In total, 36 associations were significant at a genome-
wide level as some of the 29 lead SNPs were associated with
more than one trait. Of these 36 associations, 16 included traits
in quadrant II (nose, Figure 1), 12 in quadrant I (philtrum),
5 in quadrant III (mandible), 2 in quadrant IV (upper face),
and lastly 1 association in segment 2 (midface, Figure 5).
Nine out of 29 lead SNPs also passed the study-wide threshold
(p < 8.47 × 10−10). SNP information and meta-analysis statistics
FIGURE 2 | PLSR results. PLSR statistics of unaffected parents versus unselected individuals, showing (A) the effect size (R2) and (B) the -log10(p-values) in all 63
segments. (A) Larger circle size indicates a larger effect size or a lower p-value (B). In panel (B), a yellow outer circle indicates nominal significance in that segment
(p < 0.05).
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FIGURE 3 | Endophenotypic traits. Visualization of the endophenotypic traits by exaggerating the traits in the direction of the control group (gray) and the NSCL/P
relative group (orange). (A) Segment 1, (B) Segment 2, (C) Segment 6, and (D) Segment 7.
of the 29 best associations (lowest p-value of all associated traits)
are given in Table 2. Supplementary Table 1 contains additional
information on the regression statistics and information for all
36 significant associations. Twenty-two of the lead SNPs lie in
proximity (±500 kb) to lead SNPs identified in a prior normal
facial variation GWAS (White et al., 2020a). Sixteen lead SNPs
showed strong evidence for a role in risk for OFC, another 12
showed weaker evidence (Supplementary Table 2).
Associations of the 59 endophenotypic traits with polygenic
risk scores calculated across different p-value inclusion thresholds
are visualized in Figure 6. In the United States cohort, the
strongest associations occurred in polygenic risk scores calculated
with inclusion thresholds around 0.1. The endophenotypic
traits showing the strongest associations are present in the
forehead, eye, and nose tip regions (Figure 6). The strongest
associations in the United Kingdom cohort were found between
the endophenotypic traits and polygenic risk scores calculated
using a p-value inclusion threshold around 0.001. The traits
responsible for these associations are localized in the philtrum
area (Figure 6).
DISCUSSION
Orofacial clefting has a wide range of expression and severity
(Marazita, 2012). CL/P can occur bilaterally or unilaterally and
is generally considered distinct from cleft palate only (CPO),
based on embryological and epidemiological considerations
(Roosenboom et al., 2017). The range of severity also includes
minor defects and subclinical phenotypes, which are on the
mild side of the severity spectrum. One of those subclinical
phenotypes includes subtle alterations in facial shape—a facial
endophenotype indicative of NSCL/P risk. Unaffected members
of families with a history of OFC have been found to show
a broadening of the upper face and midfacial retrusion in
comparison to control groups with no family history of clefting
(Weinberg et al., 2009; Roosenboom et al., 2015, 2017). These
endophenotypic features were confirmed in this work, where
unaffected parents also showed an upturned nose and a
protrusion of the chin.
Although several studies have confirmed the presence of
a facial endophenotype for NSCL/P in unaffected relatives,
a biological cause during embryonic development remains
speculative. Lip formation happens around week 6 of gestation,
and CL/P occurs when the nasal and maxillary prominences
fail to fuse (Marazita, 2012). This could be the result of a
failure of prominence growth and/or alignment due to the shape
of the face and the direction of growth of the prominences.
Mouse strains at higher risk for spontaneous clefting have been
shown to exhibit unique patterns in the orientation of the
facial prominences forming the lip and palate (Trasler, 1968;
Juriloff and Trasler, 1976; Millicovsky et al., 1982; Young et al.,
2007; Parsons et al., 2008). Mouse studies including mutants
in TFAP2A [MIM: 107580], a gene implicated in CL/P, have
suggested small gene expression changes altering the growth
and shape of the facial prominences as a possible cause for
the development of a cleft (Green et al., 2015). Accordingly,
cleft risk variants might influence the shape of embryological
structures in a way that complicates proper alignment for
fusion. If fusion succeeds however, the altered shape could
result in the facial endophenotype. This idea is supported
by our endophenotype GWAS, in which the lead SNPs were
predominantly associated with traits in the nasal and philtrum
area (80% of the genome-wide associations were with traits in
this area), the regions developed from the nasal and maxillary
prominences. Thus, there is a clear intersection between normal
facial development and shape alterations potentially leading to
malformations such as CL/P.
In our GWAS of endophenotypes, 22 of the 29 lead SNPs
among associated loci were found in vicinity (±500 kb) of the lead
SNPs from a previous GWAS of normal facial variation (White
et al., 2020a). The overlap of the endophenotypes with normal
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FIGURE 4 | Manhattan plot. A Manhattan plot of the meta-analysis p-values of the endophenotypic traits GWAS. The horizontal line represents the genome-wide
significance threshold (p < 5 × 10−8). The 29 lead SNPs are labeled with RS-numbers in dark blue if there is overlap with a GWAS on normal facial variation (White
et al., 2020a), and light blue if there is no overlap. The triangle, circle, and square symbols mark strong, weak, and no evidence for a role of the lead SNP in orofacial
clefting, respectively.
FIGURE 5 | Meta-analysis phenotype hits. Percentage of all genome-wide associations (p < 5 × 10−8) that occurred in quadrant I or the philtrum quadrant (red),
quadrant II or the nasal quadrant (orange), quadrant III or the mandibular quadrant (light blue), quadrant IV or the upper facial quadrant (dark blue) or in segment 2,
which covers the nose and philtrum area (light orange).
facial variation is substantial and expected. The endophenotypic
traits were established by analyzing unaffected parents’ facial
shape, yet tested in a sample of normal facial variation where a
family history of cleft was absent or unknown. An intersection
between the genetic pathways of NSCL/P and normal facial
variation was already implicated by the influence of NSCL/P
risk variants on normal facial variation. Boehringer et al. found
associations between two NSCL/P loci and bizygomatic distance
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TABLE 2 | Meta-analysis results.
RS Chr Pos Locus A1 A2 MAF US MAF UK Beta SE p-value Segment
rs4523542 1 60996971 1p31.3 T C 0.49 0.50 −0.0293 0.0052 1.53E-08 47
rs56399962 1 68159266 1p31.3 T A 0.23 0.22 −0.0203 0.0036 2.09E-08 4
rs1766793 1 119466374 1p12 G T 0.29 0.29 −0.0427 0.0063 1.76E-11 41
rs4952552 2 42198217 2p21 A G 0.45 0.44 −0.0401 0.0057 2.65E-12 43
rs921119 2 45272812 2p21 C T 0.29 0.30 0.0446 0.005 8.71E-19 34
rs970797 2 177111819 2q31.1 T G 0.43 0.43 0.0467 0.0061 1.38E-14 33
rs2855266 2 223072019 2q36.1 A T 0.14 0.15 0.0597 0.0083 5.59E-13 46
rs17054293 3 54724560 3p14.3 A T 0.27 0.27 −0.0424 0.0068 4.02E-10 33
rs4677030 3 71230514 3p14.1 A G 0.42 0.41 −0.0246 0.0044 2.00E-08 23
rs12497589 3 184464709 3q27.1 A G 0.34 0.34 0.0193 0.0035 2.40E-08 24
rs2578135 4 94864577 4q22.2 T C 0.48 0.47 0.0212 0.0038 2.12E-08 53
rs7694450 4 121998104 4q27 A G 0.45 0.43 0.0298 0.005 2.32E-09 39
rs57106444 5 67765894 5q13.1 G GTT 0.15 0.14 −0.0258 0.0046 1.67E-08 60
rs2326766 6 6393064 6p25.1 T C 0.42 0.43 0.0272 0.0046 2.45E-09 37
rs149228310 6 51091163 6p12.3 G A 0.39 0.38 −0.0251 0.0044 9.08E-09 45
rs788506 6 51703012 6p12.2 T A 0.38 0.36 −0.023 0.004 8.80E-09 44
rs846274 7 42061986 7p13 A G 0.43 0.44 −0.0232 0.0042 4.11E-08 45
rs798685 7 121985541 7q31.32 T C 0.26 0.29 0.0341 0.0047 5.74E-13 45
rs56009112 9 94480903 9q22.31 A G 0.31 0.32 −0.0148 0.0026 7.24E-09 2
rs3763605 9 96420390 9q22.32 A G 0.34 0.34 0.032 0.0058 3.60E-08 16
rs11116771 12 85686488 12q21.32 T C 0.35 0.35 0.0289 0.0048 1.81E-09 37
rs1614202 15 57716048 15q22.2 G A 0.41 0.39 0.0247 0.0044 2.59E-08 59
rs12591454 15 71876010 15q24.1 A G 0.33 0.33 −0.0359 0.0064 2.06E-08 33
rs113689916 17 1196526 17p13.3 T C 0.02 0.01 −0.1408 0.0241 4.97E-09 35
rs9915190 17 69142628 17q25.1 A C 0.37 0.41 −0.0434 0.0061 1.14E-12 40
rs759493 17 70036558 17q25.1 C T 0.42 0.41 0.0308 0.0054 1.05E-08 47
rs4805059 19 34294901 19q12 A G 0.48 0.47 −0.0307 0.0053 8.51E-09 47
rs4812393 20 38073575 20q12 T C 0.46 0.48 0.0202 0.0033 8.96E-10 26
rs3091552 20 45440006 20q13.12 C G 0.24 0.25 0.0351 0.0054 9.63E-11 45
Lead SNPs reaching at least genome-wide significance (p < 5 × 10−8). For each SNP, this table contains the RS-number (RS), chromosome (Chr), position (Pos,
GRCh37/hg19), cytogenetic band (Locus), minor allele (A1), major allele (A2), minor allele frequency in the United States cohort (MAF US), minor allele frequency in the
United Kingdom cohort (MAF UK), meta-analysis regression coefficient (Beta), meta-analysis standard error (SE), meta-analysis p-value (p-value), and the segment in
which the endophenotypic trait showing the highest association with the lead SNP was identified in (Segment).
and nose width (Boehringer et al., 2011). In previous work, we
found six NSCL/P risk variants affecting nose, chin, eyebrow
ridge, and philtrum 3D shape in the larger unselected population
(Indencleef et al., 2018). One of those six variants, rs6740960,
has been shown to play a role in both NSCL/P and normal facial
variation in multiple studies. In a normal facial variation GWAS
conducted by our group, rs6740960 was associated with shape in
the mandibular area (Claes et al., 2018). The same variant was
associated with NSCL/P in a multi-ethnic meta-analysis (Ludwig
et al., 2017). In this work, rs4952552 (17 kb from rs6740960)
was associated with segment 43, which covers small regions on
the outer sides of the nostrils. Our results indicate a strong
overlap in the underlying genetics of the NSCL/P endophenotype
and normal facial variation, with rs6740960 as an example of
this intersection.
The facial endophenotype is hypothesized to be an expression
of NSCL/P susceptibility genes. In this work, 16 of the 29 lead
SNPs also have substantial evidence for a role in OFC and 12
other lead SNPs show weaker evidence (Supplementary Table 2).
Of special interest are the seven lead SNPs implicated with OFC
that did not show an overlap with normal facial variation, which
will be discussed here. One of these variants is rs56399962, an
SNP located in 1p31.3. A clinical report covering a patient with a
deletion in 1p31 described a unique form of OFC manifesting as
a facial midline defect in both the lower and upper lip (Y1ld1r1m
et al., 2014). In a family based study, rs787499, an SNP 87 kb from
rs56399962, was associated with NSCL/P (Camargo et al., 2012).
This variant is also 404 kb from WLS [MIM: 611514], of which
expressed mRNA and protein have been found in the embryonic
development of the lip and palate in mice (Yu et al., 2010). WLS
deletion in mice has resulted in abnormal palate development (Fu
et al., 2011). In zebrafish, this gene was shown to be involved
in palate morphogenesis (Rochard et al., 2016). These findings
show that rs56399962 is located in a possible risk locus for
NSCL/P, with WLS as a candidate gene. Another SNP associated
with NSCL/P endophenotypes in our study, rs2578135, is 169 kb
from a transcript variant of GRID2 [MIM: 602368], a gene that
showed suggestive evidence (p-value = 7.9 × 10−7) with NSCL/P
in a GWAS with an Asian cohort (Beaty et al., 2010). GRID2
has also shown evidence for a gene-smoking interaction effect
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FIGURE 6 | Associations between polygenic risk scores and endophenotypic scores. (A) The -log10 p-values of the association (y-axis) plotted against
−log10(p-value inclusion thresholds) (x-axis) in the United States cohort (left) and the United Kingdom cohort (right). For both cohorts, only the six strongest
associated endophenotypic traits are depicted following the inset legends. The horizontal line represents a p-value of 0.05. (B) The minimal association
−log10(p-value) across all p-value inclusion thresholds was plotted for each segment in the United States cohort (left) and the United Kingdom cohort (right).
Encircled segments show associations of p-value < 0.0013 (0.05/38 independent traits, calculated from the 59 traits tested).
for CL/P (Beaty et al., 2013). Another SNP, rs57106444, which
is 250 kb from rs831227, showed a suggestive association (p-
value = 5.34 × 10−7) in a POFC multi-ethnic GWAS for NSCL/P
(Leslie et al., 2016). PIK3R1 [MIM: 171833], a gene 168 kb
from rs57106444, was differentially expressed in association with
NSCL/P (Wang et al., 2016). F13A1 [MIM: 134570] is a gene
located 72 kb from rs2326766 in 6p25.1, which was associated
with an endophenotypic trait in the philtrum. This gene was
suggested as a candidate gene in a NSCL/P linkage study, but
this result has not been replicated (Eiberg et al., 1987). Although
6p23 has been a candidate locus for NSCL/P in various studies,
five individuals with isolated 6p25 deletions have been reported
with a high or cleft palate (Carinci et al., n.d.; Scapoli et al.,
1997; Linhares et al., 2015). The variant identified in 15q22.2
(rs2326766) lies in the same chromosomal band but still 5MB
from a SNP that was suggestively associated with NSCL/P (de
Aquino et al., 2014). Another variant, rs113689916, located in
17p13.3 and associated with an endophenotypic trait in the
philtrum, lies within a microduplication site for which the
syndromic phenotype shows CL/P (Curry et al., 2013; Tucker
and Escobar, 2014; Ibitoye et al., 2015). Lastly, rs3091552 is
associated with an endophenotypic trait in the nose and showed
a suggestive association (p = 2.5 × 10−5) in a previous NSCL/P
GWAS (Leslie et al., 2017). The SNP is located in 20q13.12, the
duplication of which has caused cleft lip/palate in two clinical
cases (Blanc et al., 2008). One familial case of Galloway-Mowat
syndrome [MIM: 617730] due to a novel TP53RK [MIM: 608679]
mutation, a gene within 500 kb of rs3091552, also showed a
cleft palate (Hyun et al., 2018). Although these seven variants
have not yet been significantly associated with either normal
facial variation or NSCL/P in a GWAS, these results imply that
they are new candidate risk variants for NSCL/P in a European
population, with a potential additional role in normal facial
variation.
The strong overlap of the endophenotypic lead SNPs
and genetics of OFC indicates that the endophenotype is
an expression of NSCL/P susceptibility genes and that our
quantification method has captured this heightened susceptibility
successfully. In further support of this observation, we have
provided additional evidence by calculating polygenic risk
scores for NSCL/P and subjecting them to an association
with the endophenotypic traits. In both the United States
and United Kingdom cohorts, endophenotypic traits showed
associations with the polygenic risk scores, indicating an overall
heightened susceptibility for NSCL/P. Although associations
were found in both United States and United Kingdom cohorts,
the specific traits associated were different. The United Kingdom
cohort showed associations in the philtrum, an important area
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in lip formation during development. In the same cohort, Howe
et al. (2018) found an association between philtrum width and
an increased PRS for NSCL/P. These results indicate that variants
affecting the event of lip fusion can also influence philtrum shape.
The United States cohort showed associations in the orbital
region and in the nasal tip. During embryological development,
the nasal prominence is involved in lip formation. Even though
the forehead region does not seem to be directly involved in lip
formation, it has previously been identified as a region involved
in the facial endophenotype (Weinberg et al., 2009; Roosenboom
et al., 2015). The discordances of traits associated with the PRS
scores between the United States and United Kingdom cohorts
could be present due to a couple of reasons. First, in contrast
to the United States, the United Kingdom cohort only includes
individuals of 15 years old, which do not have fully developed
facial features. Second, the summary statistics used to calculate
the PRS are based on United States individuals. Although all are
of European ancestry, genetic differences between populations
of United States and United Kingdom are likely to exist and
influence the polygenic risk scores predicted. Lastly, the sample
sizes for calculating PRS are relatively small, and the summary
statistics were based on a GWAS of N = 1,411 individuals.
In this work, we tested a range of inclusion thresholds
for the polygenic risk scores. However, the common practice
is to determine an optimal inclusion threshold in another
independent dataset (Dudbridge, 2013), which was not available
in this work. For most polygenic traits, the more the SNPs
included in the polygenic risk model, the higher the predictive
power (Dudbridge, 2013). This often leads to relatively high
optimal inclusion thresholds such as p < 0.5. In a study by Ludwig
et al. (2017), the optimum inclusion threshold for NSCL/P
polygenic risk scores was p < 0.2. In contrast, Howe et al. (2018)
found P < 10−5 to be the optimum inclusion p-value and thus
included a lower number of SNPs. Consequently, the optimum
p-value inclusion threshold seems to be strongly dependent on
the trait as well as the datasets used. Linkage disequilibrium score
regression is a method in which genetic correlations between
different traits are estimated, yet unfortunately our sample sizes
did not meet the criteria for this analysis.
In this study, we focused our analyses on individuals of
European ancestry. To analyze possible population similarities
and differences in both OFC genetics as well as normal facial
genetics, future analyses should focus on individuals of other
ancestries. For example in the context of NSCL/P GWA-studies,
evidence for the gene desert 8q24 is consistently strong in
European ancestry groups, but less so in Asian ancestry groups
(Beaty et al., 2016). Inclusion of more diverse populations in
human genetics studies is of great importance, because the
current bias for European ancestry can translate into a poor
disease prediction and treatment for individuals of under-
represented ancestries (Sirugo et al., 2019). Another limitation
of this study is the lack of additional datasets to replicate the
genetic associations found, as well as the polygenic risk scores.
More specifically in the PRS analysis, additional datasets would
be most beneficial to identify the optimum p-value inclusion
threshold. A third limitation is that the unselected individuals are
extracted from different databases in which extensive filtering was
necessary. Additionally, only the unselected individuals included
from our collaboration with Pittsburgh were checked for a family
history of OFC, and excluded if it was indeed so. Lastly, no
functional analyses were performed to further investigate the role
of the loci discovered in OFC. This would be of great interest for
future analyses.
This study is the first to identify facial endophenotypic traits
for NSCL/P based on a comprehensive global-to-local facial
phenotyping approach. We have used these traits to examine
their underlying genetic architecture and observed a substantial
link between the endophenotypic traits and NSCL/P genetics,
with 16 of our lead SNPs possessing strong literature evidence
for an association with NSCL/P and an additional 12 SNPs
having weaker literature evidence. We identified seven variants
as possible new candidate risk loci for NSCL/P. Furthermore,
endophenotypic traits also indicated an overall heightened
NSCL/P susceptibility based on polygenic risk scores. This
study delivers additional evidence for the existence of the facial
endophenotype as an expression of NSCL/P susceptibility genes.
Our study shows that 76% of our lead SNPs are also associated
with normal facial variation. Therefore, and in conclusion,
this study contributes to the understanding of the intersection
of NSCL/P genetics and the genetic architecture of normal
facial variation.
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